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1. Introduction 
Haematopoietic stem cells (HSC) have the exceptional capacity to undergo continuous self-
renewal and differentiation into multiple lineages, which is essential for haematopoietic 
homeostasis and response to injury. To achieve this life long function, these cells have to be 
protected from cytotoxic and genetic damage. On the other hand, rapid activation of 
haematopoietic stem cell proliferation in response to stimuli must be ensured. While cellular 
quiescence is thought to be the key mechanism underlying this paradoxical nature of HSC, 
the molecular basis of induction and maintenance of quiescence remains unresolved.  
Quiescence is commonly defined as a reversible cell cycle exit. Induction and maintenance 
of stem cell quiescence has been studied at the level of cell cycle regulation (Orford & 
Scadden, 2008), cellular metabolism (Tothova & Gilliland, 2007) or interaction with the 
specific niche (Fuchs et al., 2004). Genome-wide association studies have been performed on 
a variety of quiescent model systems, such as serum starvation of fibroblasts (Coller et al., 
2006), primary lymphocytes (Garriga et al., 1998) or yeast in stationary phase (Patturajan et 
al., 1998, Radonjic et al., 2005). All of these studies revealed a significant decrease of 
productive mRNA transcription in these model systems. However, if quiescent adult stem 
cells share this down regulation of mRNA transcription has never been examined. 
Due to their relative ease of isolation, cells of the haematopoietic lineage have been 
extensively studied. Importantly, several assays for hematopoietic stem cell function have 
been developed, such as colony forming ability and rescue of lethally irradiated mice. These 
functional tests are lacking in most other adult stem cell models, with the exception of 
spermatogonia and mammary gland stem cells (Brinster & Nagano, 1998, Shackleton et al., 
2006). Functional assays for HSC ability have provided us with the notion that most defined 
populations of long term repopulating HSC still contain progenitor cells, which can only 
transiently contribute to repopulation of the haematopoietic system. This heterogeneity is 
not only evident in defined cell populations, but also in the in vivo niche for HSC, the bone 
marrow. HSC in the bone marrow are interspersed with transient amplifying cells and 
differentiated cells, complicating stem cell identification by spatial organization of the 
tissue. Other stem cell systems, such as spermatogonia, keratinocyte or crypt stem cells have 
a clearly defined niche architecture, enabling stem cell identification by location only (Fuchs 
et al., 2004). In this case, resting stem cells and activated progenitors can be separated by 
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location and molecular markers can be easily identified. If all adult stem cells share a 
repertoire of molecular markers, findings from other adult stem cells can be transferred to 
HSC and should lead to characterization of haematopoietic stem cell subpopulations.   
In our previous work, we found that adult melanocyte stem cells exhibit a 10 to 100fold 
lower level of housekeeping gene mRNA compared to differentiated cells, suggesting a 
global repression of mRNA transcription (Osawa et al., 2005). We could then show that the 
largest subunit of RNA polymerase II (RNApII), which is responsible for all mRNA 
transcription, exhibits a partly phosphorylated C-terminal domain (CTD), characteristic of 
initiated, but paused mRNA transcription (Freter et al., 2010). In line with this, we found the 
RNApII kinase CDK9 absent in adult melanocyte stem cells. Inhibition of CDK9 resulted in 
cellular resistance to withdrawal of essential growth factors, conferring a stem cell-like 
phenotype to progenitor cells. Interestingly, various other adult stem cells, including 
keratinocyte, muscle, spermatogonia and also HSC exhibited a similar partial 
phosphorylation of RNApII (Freter et al., 2010). We concluded that transcriptional 
quiescence is an early, specific and conserved marker for adult stem cells. This feature can 
be used to isolate and characterize pure populations of stem cell-like cells from any tissue, 
enabling a deeper understanding of stem cell biology and recapitulation of the stem cell 
niche, in order to expand immature stem cells in vitro. 
In this chapter I would like to summarize our findings that HSC exhibit a reduction in 
productive mRNA transcription. I would like to elaborate on the implications arising from 
transcriptional quiescence of a subset of HSC, both in development and disease. Technical 
challenges and resulting applications of identifying and isolating transcriptionally quiescent 
HSC in vitro will be discussed. 
2. The mRNA transcription cycle 
Regulation of gene expression is essential for all single- and multi cellular organisms. This 
fundamental process is executed at the level of mRNA transcription by RNApII, typically in 
distinct transcription steps. The different stages of mRNA transcription, initiation, promoter 
clearance, elongation, mRNA processing and release of RNApII from DNA are tightly 
regulated by modifications of the CTD of RNApII (Sims et al., 2004, Fig1). This characteristic 
domain is in mammalian cells composed of 52 repeats of the consensus sequence YS2PTS5PS. 
During mRNA transcription several posttranslational modifications of the CTD are 
occurring, most prominently phosphorylation of Serine 5 (Ser5) and Serine 2 (Ser2). These 
phosphorylation events are requisite for binding of proteins essential for RNA processing, 
splicing and polyadenylation. Using antibodies specifically detecting these phosphorylation 
events enables determination of global mRNA transcription activity in single cells in vivo. 
Gene expression in mammalian cells has been comprehensively studied at the transcription 
initiation step that is controlled by cell-specific transcription factors. In fact, it has been 
thought for long time that assembly of the preinitiation complex and subsequent 
recruitment on RNApII is the rate-limiting step for gene transcription. However, early 
results indicated that RNApII is initiated, but paused at Drosophila heat shock genes 
(Boehm et al., 2003, Ni et al., 2004). More recently, it was observed using genome-wide 
association studies that initiated but stalled polymerase  is not only present on immediate-
response or developmentally regulated genes, but also many non-expressed genes, 
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suggesting transcription elongation as the critical step in gene expression (Guenther et al., 
2007, Muse et al., 2007, Zeitlinger et al., 2007).  
Transcription initiation requires phosphorylation of Ser5 of the CTD by TFIIH, a 
heterodimeric kinase consisting of CDK7 and Cyclin H. These phosphorylation events 
enable binding of the mRNA capping machinery (Ho & Shuman, 1999) and promoter 
clearance. Typically, a short (~40nt) nascent RNA is then produced by RNApII. However, 
mRNA transcription is paused at many genes due to the action of negative elongation factor 
(NELF) and DRB-sensitivity inducing factor (DSIF) (Wu et al., 2003, Yamaguchi et al., 2002).  
 
Fig. 1. The mRNA transcription cycle is characterized by phosphorylation of the RNA 
polymerase (RNApII) CTD. Phosphorylation of Ser5 (5) by CDK7/Cyclin H induces 
promoter clearance and pre-mRNA capping. RNApII is then halted (STOP), until activation 
of CDK9/Cyclin T. Phosphorylation of the inhibitory complex and RNA polymerase II CTD 
Ser2 (2) leads to productive elongation and release of mature mRNA.  
Recruitment of positive transcription elongation factor b (P-TEFb), a heterodimeric protein 
consisting of the kinase CDK9 and one of the regulatory subunits Cyclin T1, T2 or K, to 
stalled polymerases is required for alleviation of the transcriptional block by NELF and 
DSIF (Peterlin & Price, 2006, Rahl et al., 2010). P-TEFb phosphorylates RNA recognition 
motif-containing protein RD, a component of NELF, and Spt5, a subunit of DSIF (Aida et al., 
2006, Fujinaga et al., 2004). NELF then dissociates from RNApII, while DSIF remains 
associated with RNApII and becomes a positive transcription elongation factor (Chen et al., 
2009). Importantly, phosphorylation of Ser2 of the CTD by P-TEFb triggers transcription 
elongation, mRNA processing, and release of mature mRNA (Kohoutek, 2009, Ni et al., 
2004).  
CDK9 has first been identified as a CDC2-related kinase with a PITALRE motif (Grana et al., 
1994). The cyclin partner of CDK9 is Cyclin T1, T2 or K.  Unlike other CDK/Cyclin 
heterodimers, neither P-TEFb levels nor kinase activity is fluctuating during the cell cycle 
(Garriga et al., 2003, Grana et al., 1994). CDK9 exists in two isoforms, a major 42kD sized 
peptide and an N-terminal extended peptide, whose transcription starts from an alternative 
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TATA box upstream of the housekeeping-type promoter of the 42kD isoform (Shore et al., 
2003). The expression of both isoforms varies between developmental stages and organs 
(Shore et al., 2005). For example, the expressed isoform shifts from the longer 55kD form to 
the shorter 42kD isoform during lymphocyte activation (Liu & Herrmann, 2005). However, 
the target gene specificity is very similar between the two isoforms (Liu & Herrmann, 2005).  
P-TEFb is present in the cell as either a large or small multiprotein complex. The inactive, 
large complex consists of 7SK non-coding RNA, Hexim1, LARP7 and MEPCE (Li et al., 
2005), while the small, active complex is formed by binding of Brd4 to P-TEFb (Yang et al., 
2005). Brd4 binds to acetylated histones and may therefore target P-TEFb to actively 
transcribed genes, when no specific transcription factor is present (Jang et al., 2005)  but can 
also recruit P-TEFb to inducibly acetylated histones (Hargreaves et al., 2009). However, even 
the large complex contains primarily active P-TEFb, which is sequestered away from the 
kinase targets. Cellular stresses, such as UV irradiation, cytokines or changes in the 
microenvironment result in release of active P-TEFb to support quick mRNA transcription 
to respond to stimuli. Several transcription factors have been shown to interact directly with 
P-TEFb to stimulate transcription elongation of RNApII. These include NF-kB (Barboric et 
al., 2001), c-Myc (Eberhardy & Farnham, 2001), CIITA (Kanazawa et al., 2000), GATA1 
(Elagib et al., 2008) and Runx1 (Jiang et al., 2005), amongst others. Thus, P-TEFb can be either 
recruited directly to promoters by specific transcription factors or to acetylated histones by 
Brd4. 
Phosphorylation of Ser2 in the CTD of RNApII and productive transcription elongation is 
the critical target for eukaryotic gene expression (Bentley, 1995, Chao & Price, 2001). 
Inhibition of the CTD Ser2 kinase CDK9 by 5,6-Dichloro-1-β-D-
ribofuranosylbenzimidazole (DRB) or Flavopiridol results in degradation of most mRNA 
(Chao & Price, 2001, Sehgal & Darnell, 1976) and induces apoptosis (Chen et al., 2005, Gojo 
et al., 2002). Similarly, knockdown of CDK9 in vivo results in complete absence of mRNA 
synthesis and embryonic lethality (Eissenberg et al., 2007, Shim et al., 2002). Cyclin T1 KO 
mice exhibit minor immunological defects (Oven et al., 2007), while the Cyclin T2 KO 
mouse is embryonic lethal (Kohoutek et al., 2009) with an extremely early phenotype 
before implantation of the blastocyst. This difference in phenotype of CDK9 Cyclin 
partners can partly be explained by a limited overlap in target genes of these isoforms 
(Ramakrishnan et al., 2011).  
On the other hand, ectopic activation of P-TEFb by ablation of Hexim1 results in embryonic 
lethality as well, due to hypertrophy of the heart (Huang et al., 2004). Similarly, inactivation 
of the inhibitory large complex member LARP7 results in aberrant splicing and embryonic 
death in zebrafish, highlighting the essential role of P-TEFb for pre-mRNA splicing 
(Barboric et al., 2009). However, overexpression of CDK9 from the endogenous Rosa26 
promoter did not result in any phenotype in mice, mainly due to a low level of expression of 
CDK9 from this promoter (Freter et al., 2010). Limiting P-TEFb activity is necessary for 
development of germ line cells in both D. melanogaster and C. elegance (Batchelder et al., 
1999, Hanyu-Nakamura et al., 2008, Zhang et al., 2003). Ectopic activation of P-TEFb by 
overexpression or knock down of inhibitors results in misexpression of somatic genes in 
germ line cells and their subsequent degeneration, resulting in sterile offspring. In 
summary, levels of P-TEFb and thus the global activity of RNApII need to be maintained 
within a certain limits, not exceeding and not below a basal threshold. 
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Most cells, including proliferating, terminally differentiated and senescent cells, actively 
synthesize mRNA. In these cells, RNApII is phosphorylated on CTD Ser2 and Ser5 
independent of the cell cycle (Garriga et al., 2003, Marshall et al., 2005). However, some cells 
do not display this active phosphorylation pattern. For example, deeply dormant cells, such 
as primary T and B lymphocytes, exhibit an almost complete absence of RNApII 
phosphorylation (Garriga et al., 1998, Marshall et al., 2005). Activation of these cells by 
antigen encounter results in upregulation of Ccnt1 both on mRNA and protein level and 
subsequent phosphorylation of CTD Ser2 (Marshall et al., 2005). 
On the other hand, RNApII in yeast cells in the stationary phase (Patturajan et al., 1998, 
Radonjic et al., 2005) or on Drosophila heat shock genes (Boehm et al., 2003, Ni et al., 2004) is 
phosphorylated on Ser5, but not on Ser2. Stimulation of these cells, such as the addition of 
nutrients or heat shock, ensures rapid activation of gene transcription. Thus, analysis of the 
specific phosphorylated sites in RNApII can distinguish cells featuring phases of productive 
mRNA elongation or paused mRNA transcription initiation.  
3. mRNA transcription in the hematopoietic lineage 
Most of our knowledge of P-TEFb function derived from studies involving HIV replication 
(Barboric & Peterlin, 2005). Human Cyclin T1 is an essential co-factor of the immediate-early 
HIV gene product Tat, which recruits P-TEFb to the tar RNA located 5’ on HIV genes to 
activate gene expression (Mancebo et al., 1997, Zhu et al., 1997). In resting lymphocytes, P-
TEFb activity is low and thus HIV replication is blocked. Upon stimulation, upregulation of 
Cyclin T1 results in activation of P-TEFb and transcription of viral genes (Garriga et al., 
1998). Human Cyclin T1 (Ccnt1), the major Cyclin associated with CDK9, is characterized by 
a TAR recognition motif, which is essential for the formation of a ternary complex between 
tar RNA/Tat and P-TEFb to activate HIV gene transcription in cells (Wei et al., 1998). This 
motif contains an essential Cysteine, which is required for complex formation with HIV Tat. 
Mutagenesis of mouse Ccnt1 at this position, which normally contains a Tyrosine in mouse, 
activates HIV transcription in murine cells (Fujinaga et al., 2002).  
P-TEFb is also required for normal hematopoietic development and function. Knock down 
of CDK9 in zebrafish embryos results in severe defects in definitive erythropoiesis, but no 
gross developmental defects despite a smaller body size (Meier et al., 2006). Given the 
ubiquitous requirement of CDK9 for mRNA transcription this surprising observation may 
be explained by incomplete knockdown using morpholino DNA. Similarly, partial depletion 
of Ccnt1 in mice results in modest immunological phenotypes, such as appearance of 
autoimmunity due to impaired negative selection of autoreactive T cells in thymus (Oven et 
al., 2007). Together, these results suggest that the hematopoietic lineage may be very 
susceptible for small changes in P-TEFb activity. 
Recruitment of P-TEFb by transcription factors to heterochromatin converts this general 
elongation factor to a repressor of transcription. Runx1 binds the CD4 silencer in thymocytes 
and leads to active suppression of CD4 transcription during development. Interestingly, 
despite an engaged RNApII on the CD4 promoter and in the presence of an active CD4 
enhancer in these cells, CD4 transcription is silenced (Jiang et al., 2005). This is achieved by 
binding of Cyclin T1 to Runx1 and sequestering of P-TEFb into inactive chromatin loops 
(Jiang & Peterlin, 2008). Thus, inactive genes can be loaded with a poised polymerase and 
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induction of chromatin remodelling complexes result in rapid activation of gene 
transcription by release of active P-TEFb from adjacent loci (Jiang & Peterlin, 2008). In this 
sense, assembly of the transcriptional machinery on inactive promoters can be seen as a 
transcription bookmark, to facilitate future expression.  
Activation of hematopoietic gene transcription can also be achieved via binding of P-TEFb 
to actively acetylated chromatin. Studies on LPS-induced inflammatory gene expression in 
macrophages revealed that primary response genes have a stalled polymerase at their 
promoters, already phosphorylated at Ser5 of the CTD (Hargreaves et al., 2009). In response 
to LPS stimulation, acetylation of H4K5/8/12 recruits Brd4, this in turn engages P-TEFb 
leading to CTD Ser2 phosphorylation and mRNA transcription (Hargreaves et al., 2009). 
Hematopoietic lineages are very susceptible for inhibition of P-TEFb activity and require 
specific co-factors for their respective differentiation. For example, differentiating 
macrophages and murine erythroleukemic cells down regulate the 42kD isoform, and up 
regulate the 55 kD isoform of CDK9 (Liu & Herrmann, 2005). Megakaryocyte differentiation 
depends on activation of P-TEFb and can be blocked by CDK9 inhibitors or dominant 
negative CDK9 (Elagib et al., 2008). Erythroid differentiation depends on stabilization of a 
GATA-1/SCL/LMO2 complex on β-globin chromatin, subsequent association of P-TEFb 
and RNApII Ser2 phosphorylation in the locus by the ubiquitous enhancer 
facilitator/chromatin factor Ldb1 (Song et al., 2010). Interestingly, deletion of Ldb1 in vivo 
results in defects in adult haematopoietic stem cell maintenance and diminished long-term 
reconstitution potential upon transplantation (Li et al., 2011). However, the authors did not 
examine activity of P-TEFb in their knock-out mice, which may be reduced and thus result 
in defects in HSC specification. Certainly, many other genes and cells depend on P-TEFb 
activity during development and differentiation. Using the hematopoietic lineage as a 
model system for the basal mRNA transcription machinery will shed light onto many 
aspects of eukaryotic mechanisms of transcription control. 
Conversely, some leukemic cancers are characterized by dysregulation of P-TEFb activity. 
Several fusion genes of the histone methytransferase MLL1 involved in chromosomal 
rearrangements leading to myeloid and lymphoblastic leukaemia associate with mRNA 
transcription elongation factor encoded by ELL or P-TEFb (Benedikt et al., 2011, Lin et al., 
2010), suggesting that one major mechanism for leukomogenesis is deregulated 
transcription elongation (Shilatifard et al., 1996). Indeed, targeting P-TEFb with the specific 
CDK9 inhibitor Flavopiridol induces apoptosis in chronic lymphocytic leukemic cells by 
suppression of short-lived anti-apoptotic genes, such as Mcl-1 (Chen et al., 2005). 
Dysregulation of P-TEFb activity is involved in several other cancer types. For example 
Hexim1, a negative regulator of P-TEFb activity, was found down regulated in invasive 
breast cancer samples compared to normal breast tissue (Wittmann et al., 2003). Exploiting 
the susceptibility of the hematopoietic lineage for disturbance of their mRNA transcription 
may result in novel targets of cancer therapy. 
4. Transcriptional quiescence of hematopoietic stem cells 
Hematopoietic stem cells (HSC) have been in the focus of basic and applied research since 
many decades. Definition of subsets of transplantable HSC and their in vitro culture have 
advanced considerably in recent years. However, so far no reliable marker for the isolation 
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of pure HSC exists and our use of transplants is limited by the inability to expand these cells 
ex vivo. A sensitive marker of HSC quiescence and activation could be useful to isolate 
unadulterated long-term repopulating HSC and screen for factors that enable stem cell 
expansion while maintaining their undifferentiated state. It has been known for three 
decades that HSC down regulate productive mRNA transcription. Low retention of Pyronin 
Y, an RNA binding dye, can be used to isolate HSC (Shapiro, 1981), suggesting that global 
suppression of mRNA transcription is a feature of quiescent HSC. However, this 
observation has not been followed up by analysis of the global status of RNApII activity, 
which is responsible for all mRNA transcription.  
We have previously observed that adult melanocyte stem cells (MelSC) down regulate many 
housekeeping genes, including ActB, ActG and GapDH, suggesting a global repression of 
mRNA synthesis in these cells (Osawa et al., 2005). Melanocytes are pigmented cells in the 
hair follicle and skin, providing melanin granules to differentiating keratinocytes. The 
MelSC system in mouse hair follicles can serve as a model system for adult stem cell 
systems. It has the advantage of spatial separation of stem and differentiated cells and a 
non-lethal but obvious hair graying phenotype if this system is perturbed (Nishimura et al., 
2002). We observed that adult MelSC show a complete absence of RNApII CTD Ser2 
phosphorylation, while Ser5 was phosphorylated (Freter et al., 2010), suggesting a global 
down regulation of productive mRNA transcription. In line with this, CDK9 protein and 
mRNA was down regulated in MelSC as well. This suggests that RNApII is present at many 
genes in quiescent MelSC, but P-TEFb levels are not sufficient to induce active transcription 
elongation. Importantly, inhibition of CDK9 in vitro protected melanocyte precursors from 
stress-induced apoptosis and converted them to a stem cell-like state (Freter et al., 2010).  
We then expanded our observation to other stem cell systems, and found CTD Ser2-negative 
cells in all stem cell systems tested, including keratinocyte, muscle, spermatogonia and 
hematopoietic stem cells. This suggests that global suppression of mRNA transcription 
elongation is a conserved feature of adult stem cells. Interestingly, some stem cell systems 
showed heterogeneity of CTD Ser2 staining. For example, we observed that spermatogonia 
stem cells attached to the basal lamina are negative for CTD Ser2 phosphorylation, while 
those detaching up-regulate Ser2 phosphorylation, even though they are still positive for the 
spermatogonia stem cell marker CD9 (Freter et al., 2010). Attachment to the basal lamina is 
often a requirement for stem cell function by directing planes of division or maintenance of 
the undifferentiated state. Thus, the CTD Ser2 negative population seems to be the more 
stem cell-like population in CD9 positive spermatogonia. 
Similarly, murine CD34- c-Kit+Sca1+Lin- (KSL) long-term repopulating hematopoietic 
stem cells clearly showed two different populations. One population exhibited CTD Ser2 
phosphorylation levels as high as short-term repopulating CD34+ KSL cells, while ~27% 
of all CD34- KSL cells were negative for CTD Ser2 phosphorylation (Freter et al., 2010). 
Heterogeneity of the HSC pool has been described previously, with a transplantable 
fraction of 15-25% of CD34- KSL HSC population, also using additional markers (Ema et 
al., 2005, Foudi et al., 2009, Wilson et al., 2008). Importantly, analysis of transcriptionally 
quiescent HSC requires isolation of pure subpopulations of cells. We found that adult 
MelSC exhibit up to 100fold lower levels of total RNA per cell (Osawa et al., 2005), 
suggesting that one activated stem cell may be sufficient to mask the RNA signal of 100 
quiescent stem cells. 
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In order to identify the transcriptionally quiescent subpopulation of CD34- KSL cells, we 
performed sorting of bone marrow cells and antibody staining of sorted populations. 
Unfortunately, this procedure always includes fixation of cells, so they can not be used for 
assessment of in vivo repopulation ability. In order to validate stem cell function in vivo, it 
is necessary to convert the negative CTD Ser2 phosphorylation event into a readout which 
can be measured in living cells. Kinase activity can be measured using fusion proteins of 
Cyan and Yellow fluorescent proteins (CFP and YFP respectively), separated by a kinase 
target, a flexible linker and a phosphoprotein binding domain. Phosphorylation events 
result in binding of the phosphoacceptor to the kinase target and folding of the fusion 
protein resulting in Foerster resonance energy transfer (FRET) between CFP and YFP (Sato 
et al., 2007). However, autofluorescence of cellular organelles in low energetic wavelengths, 
such as CFP, results in low signal to noise ratios, which is particularly difficult for cell 
sorting of multiparametric cell suspensions, such as bone marrow cells. Furthermore, even a 
complete lack of FRET by spatial separation results in FRET signal due to high concentration 
of expressed fluorescent proteins (Nguyen & Daugherty, 2005). Thus, a FRET-based 
approach can be useful for single-cell based imaging approaches, such as time lapse imaging 
of individual cells in vitro, but rather not for FACS sorting of heterogenic cell populations. 
Recently, the development of circular permuted green fluorescent proteins (cpGFP) has 
enabled researchers to measure phosphorylation events in living cells using a single 
wavelength (Kawai et al., 2004). However, the increase in fluorescence was only around 10-
15%, which would be too little for separation by FACS. Novel mutations of circular GFP and 
ratiometric measurement of absorbance at different wavelengths increased the dynamic 
range up to 16fold between free and saturated forms of cpGFP, at least for measurement of 
pH or Ca2+ in living cells (Bizzarri et al., 2006, Souslova et al., 2007). Yet, if a kinase reporter 
can be constructed using these advanced cpGFP mutants has still to be shown. 
We could observe a specific down regulation of CDK9, the RNApII CTD Ser2 kinase, in 
adult melanocyte stem cells both on the mRNA and protein levels (Freter et al., 2010). The 
CDK9 promoter has many features of a housekeeping gene promoter (Bagella et al., 2000, 
Liu & Rice, 2000), thus down regulation of this promoter may be due to a similar mechanism 
as other down regulated housekeeping genes in MelSC. Reporters for promoter function, for 
example GFP, Luciferase or LacZ have been used extensively to isolate or trace specific cells 
in vivo. However, isolating CDK9 promoter negative cells as transcriptionally quiescent 
stem cells could be biased by secondary effects on the reporter, such as silencing of reporter 
constructs or heterogeneity of expression between cells. One solution would be to label all 
cells with a constitutive reporter, and isolate constitutive promoter positive, CDK9 promoter 
reporter negative cells. The constitutive promoter has to be carefully chosen, as for example 
expression from the CMV promoter highly depends on CDK9 (Peng et al., 1998). Given our 
observation of low activity of CDK9 in HSC, it is not surprising that HSC show limited CMV 
promoter activity (Salmon et al., 2000). Constitutive promoters, but also promoters used for 
overexpression of genes in quiescent stem cells thus need to be validated for activity in vivo.  
In vitro culture and expansion of immature hematopoietic stem cells could help to achieve 
better transplantation response in patients, but has not been achieved yet. So far culture of 
immature HSC leads to almost immediate differentiation and loss of multi-lineage 
repopulation ability. It has been shown recently that the xenobiotic Aryl receptor is present 
on HSC (Singh et al., 2009). Activation by ligands results in nuclear translocation, 
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recruitment of Ccnt1 and activation of hematopoietic gene transcription (Tian et al., 2003). 
Interestingly, antagonists of the Aryl receptor prevent differentiation of HSC in vitro 
(Boitano et al., 2010), suggesting that transcriptional quiescence may be beneficial for in vitro 
stem cell expansion. It would be very interesting to determine if inhibitors of P-TEFb activity 
have an effect on maintenance of undifferentiated HSC. 
Transcriptional quiescence could also be used as a read-out of stem cell function in vitro. 
Screens of small molecular compounds in in vitro culture of primary HSC for maintenance 
of the human HSC markers CD34 and CD133 have led to some promising results (Boitano et 
al., 2010). However, surface proteins may be unstable or unreliable, and may not be an 
immediate read-out of stem cell function. Transcriptional quiescence could serve as an 
alternative marker for stem cell identity. The development of fluorescent reporters for this 
screening is required to evaluate the impact of cytokines or small molecules on maintenance 
and expansion of HSC in vitro. 
We and others have shown that inhibition of P-TEFb activity can be favourable for cell 
survival during cellular stresses, such as serum or growth factor starvation (Freter et al., 
2010, Kanazawa et al., 2003). Down regulation of P-TEFb activity could thus also be 
advantageous for cancer cell survival during metastasis or therapy. Flavopiridol, a very 
specific CDK9 inhibitor has been used in BLL with some success (Chen et al., 2005), but 
failed in most cases as a single agent in cancer chemotherapy (Blagosklonny, 2004). If 
transcriptionally quiescent cancer cells are present in primary or metastatic tumours, further 
inhibition of CDK9 activity may not be required. Rather, activation of mRNA transcription 
in these cells may render them susceptible to therapy and prevent metastasis and relapse. 
The first step towards this goal would be to identify and isolate transcriptionally quiescent 
cancer cells from a given tumour using a kinase activity reporter or CDK9 promoter 
reporter. Next, it would be necessary to determine if transcriptionally quiescent tumour cells 
have an enhanced tumour forming capacity in vivo or survive treatment with 
chemotherapeutic agents better than transcriptionally activated cells. Finally, high 
throughput screens for small molecular compounds which activate transcriptional quiescent 
cancer cells using the same reporter systems will enable us to activate dormant cancer stem 
cell-like cells in vivo and improve treatment of metastasis and prevent relapse of cancer in 
patients. 
5. Conclusion 
Adult stem cells have the unique capacity to self-renew and give rise to differentiated cells. 
To fulfil their lifelong function, these cells must be protected from cellular and genetic 
damage. Most adult stem cells are thought to enter a state of reversible cell cycle quiescence 
to preserve their role (Orford & Scadden, 2008). Indeed, activation of the cell cycle leads to 
premature stem cell exhaustion (Cheng et al., 2000, Kippin et al., 2005, Park et al., 2003). 
However, most cells in the adult body have withdrawn from the cell cycle and can be 
induced to proliferate again, resulting in their eventual depletion (Bond et al., 2004, 
Pajalunga et al., 2007). Some somatic cells are able to resume proliferation and even self-
renew, for example differentiated T and B lymphocytes (Fearon et al., 2001). It has thus been 
proposed that adult stem cells are distinguished by other mechanisms rather than cell cycle 
quiescence (Mikkers & Frisen, 2005). Yet, what kind of defining mechanisms or marker this 
property integrates, and if it is shared by various adult stem cells, is unclear at the moment. 
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It has been long known that adult HSC can be isolated by their low retention of Pyronin Y, 
an RNA binding dye (Shapiro, 1981), suggesting that global mRNA transcriptional 
quiescence is a hallmark of quiescent stem cells. This observation however, has never been 
addressed further in terms of the precise molecular mechanism underlying global 
transcriptional quiescence. Analysis of the distinct phosphorylation patterns of the CTD of 
RNApII during the different stages of mRNA transcription can reveal initiation, paused 
transcription or productive elongation. Our analysis of various adult stem cell systems 
showed that down regulation of productive mRNA transcription elongation is a conserved, 
specific and early feature of adult stem cells (Freter et al., 2010). In line with this, the CTD 
kinase CDK9 was absent and its inhibition improved cell survival during cellular stresses, 
suggesting a beneficial function of transcriptional quiescence for stem cell maintenance and 
survival. However, we could not induce activation of mRNA transcription by 
overexpression of CDK9 in vivo. It is thus not clear what the in vivo function of this down 
regulation is. New animal models with a constitutively active RNApII have to be developed 
to elucidate if transcriptional quiescence is necessary for adult stem cell maintenance or just 
a symptom of their quiescence. 
Interestingly, we could observe some heterogeneity in terms of mRNA transcription 
elongation in the HSC pool, where only 27% of cells showed a clear absence of mRNA 
transcription elongation. Yet, identification and isolation of these transcriptionally quiescent 
cells depends on the availability of genetically encoded reporters of mRNA transcription. 
CDK9 activity reporters need to be specific for this kinase, and a large dynamic range has to 
be provided to clearly separate cell populations. A particular challenge will be to convert the 
negative observation of CTD Ser2 dephosphorylation into a signal-positive output, in order 
to avoid false-positive events by untransfected cells.  
Taken together, we defined a novel molecular mechanism for adult stem cell quiescence, 
which may lead to the identification of pure stem cell-like cell populations from various 
sources, including heterogeneous adult stem cell populations or cancerous tissue. Even 
though some technical questions and functional tests are still to be answered, transcriptional 
quiescence is a novel and exciting mechanism to detect, isolate and characterize adult stem 
cells in an unprecedented purity from various sources. 
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